TABLE 5.

Short Life Expectancy Exclusion Criteria

Patient Condition	Age Group
Metastatic malignancies	Adult and pediatric
Hematologic malignancies with poor prognosis	Adult and pediatric
End-stage organ failure with expected survival < 1 y, such as end-stage cardiac failure (NYHA class IV), severe chronic lung disease, advanced hepatic failure (MELD score > 20)	Adult and pediatric
Very advanced age	Adult
Advanced and irreversibly immunocompromised, such as drug-resistant AIDS	Adult and pediatric
Congenital anomalies with expected survival < 1 y	Pediatric

MELD = Model for End-Stage Liver Disease; NYHA = New York Heart Association.